These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8302286

  • 1. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
    Fournier A, Gagnon D, Quirion R, Cadieux A, Dumont Y, Pheng LH, St-Pierre S.
    Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types.
    Dumont Y, Satoh H, Cadieux A, Taoudi-Benchekroun M, Pheng LH, St-Pierre S, Fournier A, Quirion R.
    Eur J Pharmacol; 1993 Jul 06; 238(1):37-45. PubMed ID: 8405081
    [Abstract] [Full Text] [Related]

  • 3. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
    Grundemar L, Kahl U, Callréus T, Langel U, Bienert M, Beyermann M.
    Regul Pept; 1996 Apr 23; 62(2-3):131-6. PubMed ID: 8795076
    [Abstract] [Full Text] [Related]

  • 4. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC, Fournier A, St-Pierre S, Dumont Y, Forest M, Quirion R.
    Mol Pharmacol; 1990 Oct 23; 38(4):494-502. PubMed ID: 2172766
    [Abstract] [Full Text] [Related]

  • 5. Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships.
    Jung G, Beck-Sickinger AG, Dürr H, Gaida W, Schnorrenberg G.
    Biopolymers; 1991 May 23; 31(6):613-9. PubMed ID: 1657233
    [Abstract] [Full Text] [Related]

  • 6. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y, Cadieux A, Doods H, Fournier A, Quirion R.
    Can J Physiol Pharmacol; 2000 Feb 23; 78(2):116-25. PubMed ID: 10737674
    [Abstract] [Full Text] [Related]

  • 7. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
    Michel MC, Gaida W, Beck-Sickinger AG, Wieland HA, Doods H, Dürr H, Jung G, Schnorrenberg G.
    Mol Pharmacol; 1992 Oct 23; 42(4):642-8. PubMed ID: 1331755
    [Abstract] [Full Text] [Related]

  • 8. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
    Yumoto N, Murase S, Hattori T, Yamamoto H, Tatsu Y, Yoshikawa S.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1490-5. PubMed ID: 8250906
    [Abstract] [Full Text] [Related]

  • 9. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A, Ujhelyi M, Borchers M, Huang Y, Zhai W, Zhou Y, Johnson M, Sheriff S, Fischer JE.
    J Med Chem; 1996 Mar 01; 39(5):1142-7. PubMed ID: 8676351
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN, Wienen W, Entzeroth M, Rudolf K, Eberlein W, Engel W, Wieland HA.
    J Pharmacol Exp Ther; 1995 Oct 01; 275(1):136-42. PubMed ID: 7562541
    [Abstract] [Full Text] [Related]

  • 11. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R, Bettio A, Beck-Sickinger AG, Zerbe O.
    J Mol Biol; 2001 Jan 12; 305(2):307-29. PubMed ID: 11124908
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
    Beck-Sickinger AG, Jung G.
    Biopolymers; 1995 Jan 12; 37(2):123-42. PubMed ID: 7893945
    [Abstract] [Full Text] [Related]

  • 13. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
    Wieland HA, Willim KD, Entzeroth M, Wienen W, Rudolf K, Eberlein W, Engel W, Doods HN.
    J Pharmacol Exp Ther; 1995 Oct 12; 275(1):143-9. PubMed ID: 7562543
    [Abstract] [Full Text] [Related]

  • 14. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M, Mayrhofer M, Zerbe O.
    J Mol Biol; 2004 Jun 18; 339(5):1153-68. PubMed ID: 15178255
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R.
    Neuropeptides; 2004 Aug 18; 38(4):163-74. PubMed ID: 15337369
    [Abstract] [Full Text] [Related]

  • 16. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics.
    Gurrath M, Bisello A, Bottazzo K, Chung CW, Mammi S, Peggion E.
    J Pept Sci; 1996 Aug 18; 2(3):176-93. PubMed ID: 9231326
    [Abstract] [Full Text] [Related]

  • 17. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
    Doughty MB, Hu L.
    Biopolymers; 1993 Aug 18; 33(8):1195-206. PubMed ID: 8364154
    [Abstract] [Full Text] [Related]

  • 18. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
    Grundemar L, Krstenansky JL, Håkanson R.
    Eur J Pharmacol; 1993 Mar 02; 232(2-3):271-8. PubMed ID: 8467862
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C, Beck-Sickinger AG.
    J Pept Sci; 2000 Mar 02; 6(3):97-122. PubMed ID: 10759209
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffman JA, Smiley DL, Chance RE, Lundell I, Larhammar D.
    Mol Pharmacol; 1996 Jul 02; 50(1):112-8. PubMed ID: 8700103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.